S2.
The clinical treatment history of investigated patients
| PATHNO | Gender | DXAGE | STAGE | CURRX | OS | ALIVE | EZH1 | EZH2 | PREVRX |
| PATHNO = pathology ID number; SEX = gender: 2=female, 1=male; DXAGE = age at date of diagnosis; STAGE = Ann Arbor stage; CURRX = initial therapy code: 50=W&W; 53=CAPBOP3; 63=CAPBOP4; 73=CNOP; 82=Rituxan, Fludara, Adria or Mitoxantrone, Cytoxan & VCR; 83=Fludara/R-CHOP; 84=R-CHOP->R-HyperCVAD; 91= HyperCVAD; 92=R-HyperCVAD; 93=CHOP; 94=R-CHOP; 97=R-CHOP & Bortezomib; 98=Leukeran & Prednisone; OS = overall survival in months; ALIVE = patient status, alive=0, dead=1; EZH1 = EZH1 result: low expression=0, high expression=1; EZH2 = EZH2 result: low expression=0, high expression=1; PREVRX = previous therapy given (‘-’ indicates this is ade novo case) | |||||||||
| NEB_S89-6719 | 1 | 64 | 4 | 63 | 53 | 1 | 0 | 0 | – |
| NEB_S91-1644 | 1 | 60 | 4 | 63 | 24 | 1 | 0 | 1 | – |
| NEB_S96-747 | 1 | 63 | 4 | 73 | 5 | 1 | 0 | 1 | – |
| NEB_S97-6596 | 1 | 65 | 4 | 73 | 22 | 1 | 1 | 0 | – |
| NEB_S97-9354 | 2 | 80 | 3 | 73 | 24 | 1 | 0 | 0 | – |
| NEB_S97-10825 | 2 | 59 | 4 | 73 | 20 | 1 | 0 | 1 | – |
| NEB_S97-11946 | 1 | 55 | 4 | 73 | 47 | 1 | 0 | 1 | – |
| NEB_SC01-1791 | 1 | 85 | 4 | 82 | 42 | 1 | 0 | 1 | – |
| NEB_SC04-1638 | 2 | 65 | 2 | 94 | 45 | 1 | 0 | 1 | – |
| NEB_S03-21240 | 1 | 70 | 4 | 94 | 150 | 0 | 0 | 0 | – |
| NEB_S03-19827 | 2 | 57 | 4 | 92 | 35 | 1 | 0 | 1 | – |
| NEB_S02-4321 | 1 | 46 | 4 | 92 | 161 | 0 | 0 | 0 | – |
| NEB_S02-21874 | 1 | 59 | 4 | 94 | 66 | 1 | 0 | 1 | – |
| NEB_SC05-3291 | 1 | 37 | 4 | 92 | 19 | 1 | 0 | 1 | – |
| NEB_SC03-305 | 1 | 76 | 2 | 50 | 18 | 1 | 0 | 1 | – |
| NEB_S98-12406 | 1 | 75 | 4 | 94 | 19 | 1 | 1 | 0 | – |
| NEB_SC05-3291 | 1 | 37 | 4 | 92 | 31 | 1 | 0 | 0 | – |
| NEB_SC06-760 | 1 | 73 | 4 | 94 | 16 | 1 | 0 | 1 | – |
| NEB_SC06-3687 | 1 | 88 | 3 | 98 | 0.3 | 1 | 0 | 1 | – |
| NEB_SC06-1183 | 1 | 78 | 4 | 94 | 43 | 1 | 0 | 0 | – |
| NEB_S07-463 | 1 | 71 | 4 | 97 | 35 | 1 | 0 | 1 | – |
| NEB_S07-5289 | 1 | 60 | 4 | 92 | 105 | 0 | 0 | 0 | – |
| NEB_S95-1283 | 1 | 58 | 3 | 73 | 51 | 1 | 0 | 0 | – |
| NEB_S89-3218 | 2 | 77 | 4 | 63 | 139 | 1 | 0 | 0 | – |
| NEB_SP01-5878 | 2 | 49 | 4 | 91 | 183 | 0 | 1 | 0 | – |
| TMU_344322 | 1 | 54 | 4 | 93 | 30 | 1 | 0 | 1 | – |
| TMU_362565 | 2 | 69 | 4 | 93 | 30 | 1 | 1 | 1 | – |
| TMU_363595 | 1 | 57 | 4 | 93 | 16 | 1 | 0 | 1 | – |
| TMU_364180 | 2 | 46 | 2 | 84 | 70 | 0 | 0 | 0 | – |
| TMU_395043 | 1 | 53 | 3 | 93 | 115 | 0 | 0 | 0 | – |
| TMU_395456 | 1 | 64 | 2 | 91 | 128 | 0 | 0 | 0 | – |
| TMU_398817 | 1 | 67 | 4 | 92 | 131 | 0 | 0 | 0 | – |
| TMU_411072 | 2 | 71 | 4 | 94 | 15 | 1 | 0 | 1 | – |
| TMU_412975 | 1 | 56 | 4 | 94 | 15 | 1 | 1 | 1 | – |
| TMU_418367 | 1 | 62 | 3 | 84 | 118 | 0 | 0 | 0 | – |
| TMU_425675 | 1 | 64 | 4 | 92 | 121 | 0 | 1 | 0 | – |
| TMU_435280 | 2 | 66 | 2 | 94 | 131 | 0 | 0 | 0 | – |
| TMU_435293 | 2 | 62 | 4 | 94 | 16 | 1 | 0 | 1 | – |
| TMU_438376 | 2 | 63 | 4 | 91 | 137 | 0 | 1 | 0 | – |
| TMU_444479 | 1 | 59 | 3 | 94 | 28 | 0 | 0 | 0 | – |
| TMU_446227 | 1 | 61 | 4 | 94 | 1 | 1 | 0 | 1 | – |